TH179021A - Micro RNA Compounds and Methods for Controlling MIR-21 Activations - Google Patents
Micro RNA Compounds and Methods for Controlling MIR-21 ActivationsInfo
- Publication number
- TH179021A TH179021A TH1301006081A TH1301006081A TH179021A TH 179021 A TH179021 A TH 179021A TH 1301006081 A TH1301006081 A TH 1301006081A TH 1301006081 A TH1301006081 A TH 1301006081A TH 179021 A TH179021 A TH 179021A
- Authority
- TH
- Thailand
- Prior art keywords
- mir
- activations
- methods
- fibrosis
- cancer
- Prior art date
Links
- 230000004913 activation Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 229920001239 microRNA Polymers 0.000 title 1
- 239000002679 microRNA Substances 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 claims abstract 8
- 206010016654 Fibrosis Diseases 0.000 claims abstract 4
- 230000002159 abnormal effect Effects 0.000 claims abstract 4
- 201000011510 cancer Diseases 0.000 claims abstract 4
- 201000010099 disease Diseases 0.000 claims abstract 4
- 230000000694 effects Effects 0.000 claims abstract 4
- 230000004761 fibrosis Effects 0.000 claims abstract 4
- 239000003112 inhibitor Substances 0.000 claims abstract 4
- 230000004048 modification Effects 0.000 claims abstract 4
- 238000006011 modification reaction Methods 0.000 claims abstract 4
- 239000002777 nucleoside Substances 0.000 claims abstract 4
- 150000003833 nucleoside derivatives Chemical class 0.000 claims abstract 4
- 239000000470 constituent Substances 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
Abstract
DC60 (18/11/56) ที่อธิบายในที่นี้คือองค์ประกอบและวิธีสำหรับการยับยั้งแอคทิวิตี้ miR-21 องค์ประกอบมีบางรูปแบบของการดัดแปลงนิวคลีโอไซด์ซึ่งให้ตัวยับยั้งแอคทิวิตี้ miR-21 ที่มี ประสิทธิภาพ องค์ประกอบอาจถูกใช้เพื่อยับยั้ง miR-21 และอีกทั้งรักษาโรคที่เกี่ยวข้องกับ การแสดงออกที่ผิดปกติของ miR-21 เช่นไฟโบรซิสและมะเร็ง ที่อธิบายในที่นี้คือองค์ประกอบและวิธีสำหรับการยับยั้งแอคทิวิตี้ miR-21 องค์ประกอบมีบางรูปแบบของการดัดแปลงนิวคลีโอไซด์ซึ่งให้ตัวยับยั้งแอคทิวิตี้ miR-21 ที่มี ประสิทธิภาพ องค์ประกอบอาจถูกใช้เพื่อยับยั้ง miR-21 และอีกทั้งรักษาโรคที่เกี่ยวข้องกับ การแสดงออกที่ผิดปกติของ miR-21 เช่นไฟโบรซิสและมะเร็ง สิทธิบัตรยา The DC60 (18/11/56) described here is the composition and method for inhibiting the miR-21 activity. There are some forms of nucleoside modifications that provide an activated inhibitor. The effective miR-21 constituents may be used to inhibit miR-21 and also to treat diseases associated with Abnormal expression of miR-21 such as fibrosis and cancer The constituents and methods described here are for the inhibition of miR-21 activity. There are some forms of nucleoside modifications that provide an effective miR-21 active inhibitor. May be used to inhibit miR-21 and to treat diseases related to Abnormal expression of miR-21 such as fibrosis and cancer, drug patent.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH179021A true TH179021A (en) | 2018-08-23 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018236800B2 (en) | DNA-PK inhibitors | |
| WO2015054676A3 (en) | Compositions for modulating c9orf72 expression | |
| WO2012142498A3 (en) | Mif inhibitors and their uses | |
| PH12014502387A1 (en) | Microrna compounds and methods for modulating mir-21 activity | |
| WO2012125544A3 (en) | Necroptosis inhibitors and methods of use therefor | |
| NI201600051A (en) | COMBINATIONS OF HISTONE DESACETILASE INHIBITORS AND IMMUNOMODULATING DRUGS | |
| CR20130267A (en) | NAMPT AND ROCK INHIBITORS | |
| WO2015010135A3 (en) | Compositions for modulating tau expression | |
| EP3862362A3 (en) | Conjugates of modified antisense oligonucleotides and their use for modulating pkk expression | |
| WO2015077503A8 (en) | Autotaxin inhibitor compounds | |
| WO2015031679A3 (en) | Modulation of prekallikrein (pkk) expression | |
| EA201390711A1 (en) | HYDROXYAMIDE COMPOUNDS OF Pyrimidine As Inhibitors of Protein Deacetylases and Methods for Their Use | |
| WO2012135246A3 (en) | Compositions and methods for inhibiting expression of tmprss6 gene | |
| MX2019003089A (en) | Microrna compounds and methods for modulating mir-21 activity. | |
| PH12017501095A1 (en) | Piperidine derivatives as hdac1/2 inhibitors | |
| BR112014028042A2 (en) | nampt inhibitors | |
| BR112014004319A2 (en) | compounds and compositions as c-kit kinase inhibitors | |
| MX348311B (en) | Nampt inhibitors. | |
| WO2011126842A3 (en) | Targeting micrornas for the treatment of cardiac disorders | |
| WO2013119946A8 (en) | Long chain base sphingosine kinase inhibitors | |
| WO2013006558A3 (en) | Compositions and methods for treating skeletal myopathy | |
| BR112015010196A2 (en) | methods of treating liver disease | |
| WO2011103028A3 (en) | Compositions and methods for inhibiting mmset | |
| WO2014030117A3 (en) | Cosmetic use of the essential oil of laserpitium siler l. against the signs of aging of the skin and as a skin antioxidant | |
| EP3476939A4 (en) | Nucleic acid inhibiting expression of the mex3b gene, mex3b gene expression inhibitor, method for inhibiting mex3b gene expression, and prophylactic or therapeutic agent for disease caused by mex3b gene expression |